Given that both diabetes and obesity confer high psychiatric disorder risks, an increasing number of researchers have begun investigating a potential relationship between the use of GLP-1 RAs and the occurrence of psychiatric AEs (23–25). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.